共 50 条
- [21] NEWLY DIAGNOSED GLIOBLASTOMA TREATED WITH GLIADEL® FOLLOWED BY RADIATION THERAPY (RT), TEMOZOLOMIDE AND BEVACIZUMAB, AND POST-RT BEVACIZUMAB AND TEMOZOLOMIDE: A PHASE II STUDYNEURO-ONCOLOGY, 2012, 14 : 104 - 104Desjardins, AnnickPeters, Katherine B.Herndon, James E., IIBailey, Leigh AnnAlderson, Lloyd M.Ranjan, TulikaSampson, John H.Friedman, Allan H.Bigner, Darell D.Friedman, Henry S.Vredenburgh, James J.
- [22] Temozolomide (TMZ) and bevacizumab (BV) as initial treatment for unresectable or multifocal glioblastoma multiforme (GBM)JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)Peters, K.Desjardins, A.Reardon, D. A.Perry, S.Herndon, J. E., IIBailey, L.Friedman, A. H.Friedman, H. S.Bigner, D. D.Vredenburgh, J. J.
- [23] A phase II trial of lithium, bevacizumab, temozolomide, and radiation for newly diagnosed glioblastomas (GBM).JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)Narayana, AshwathaTam, Moses M.Gruber, Deborah BethGolfinos, JohnParker, ErikZagzag, DavidGruber, Michael L.
- [24] BEVACIZUMAB (BV) IN COMBINATION TO TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM): A PHASE 2 TRIALNEURO-ONCOLOGY, 2009, 11 (05) : 634 - 634Desjardins, AnnickReardon, David A.Peters, Katherine B.Herndon, JamesKirkpatrick, JohnGururangan, SridharanSampson, John H.Friedman, Allan H.Friedman, HenryVredenburgh, James J.
- [25] Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II studyACTA ONCOLOGICA, 2014, 53 (07) : 939 - 944Hofland, Kenneth F.Hansen, SteinbjornSorensen, MortenEngelholm, SilkeSchultz, Henrik P.Muhic, AidaGrunnet, KirstenAsk, AndersCosta, Junia C.Kristiansen, CharlotteThomsen, CarstenPoulsen, Hans SkovgaardLassen, Ulrik
- [27] Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma MultiformeJOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) : 142 - 148Lai, AlbertTran, AnhNghiemphu, Phioanh L.Pope, Whitney B.Solis, Orestes E.Selch, MichaelFilka, EmeseYong, William H.Mischel, Paul S.Liau, Linda M.Phuphanich, SurasakBlack, KeithPeak, ScottGreen, Richard M.Spier, Cynthia E.Kolevska, TatjanaPolikoff, JonathanFehrenbacher, LouisElashoff, RobertCloughesy, Timothy
- [29] A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastomaNEURO-ONCOLOGY, 2014, 16 (07) : 984 - 990Clarke, Jennifer L.Molinaro, Annette M.Phillips, Joanna J.Butowski, Nicholas A.Chang, Susan M.Perry, ArieCostello, Joseph F.DeSilva, Ashley A.Rabbitt, Jane E.Prados, Michael D.
- [30] Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiformeRADIATION ONCOLOGY, 2013, 8Shields, Lisa B. E.Kadner, RobertVitaz, Todd W.Spalding, Aaron C.